Monsanto Beats and Reaffirms – Analyst Blog
Zacks Market Commentaries (October 7th, 2009) Writes:
Today before the market opened, Monsanto Co. (MON), the largest chemicals and biotech seed maker reported results for the fourth quarter of fiscal year 2009, ended August 31, 2009.
Excluding one-time items (on an ongoing basis), the company reported earnings of 2 cents per share, compared to a loss of 3 cents per share in the year-ago quarter. This was above the Zacks Consensus Estimate of 1 cent per share.
However, the company posted a wider loss in the quarter, which increased to 43 cents per share on an as-reported basis, from 31 cents in the year-ago quarter, due to restructuring charges and the divestiture of the company's sunflower operations. Restructuring lowered earnings by 53 cents.
During the quarter, the company also increased the restructuring reserve to the $550 - $600 million range to support its cost-cutting effort. SG&A as a percentage of revenue was ...
Tags for this Post:
Australia, biotech seed maker, cent;, Chemicals, genomics, India, Investing Lessons, Monsanto, Stocks to Watch, United States, USD, vegetable products, Zacks Market Commentaries
Australia, biotech seed maker, cent;, Chemicals, genomics, India, Investing Lessons, Monsanto, Stocks to Watch, United States, USD, vegetable products, Zacks Market Commentaries


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
